It is possible that the high expression of caspase-8 in tumors results in a low level of residual caspase-8 activation that cleaves enough BID to induce minority MOMP and DNA damage, leading to tumorigenesis, while full caspase-8 activation would lead to apoptosis and tumor cell removal. This evidence concerns the gene CASP8 and neoplasm.